Kirn David's Insider Trades & SAST Disclosures

Kirn David's most recent trade in 4D Molecular Therapeutics Inc was a trade of 267,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2025 267,500 267,500 - - Stock Option (Right to Buy)
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 22.49 per share. 10 Jul 2024 12,923 1,059,153 - 22.5 290,598 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.42 per share. 10 Jul 2024 11,653 1,070,806 - 14.4 168,036 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2024 11,653 565,417 - - Stock Option (Right To Buy)
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2024 1,270 148,730 - - Stock Option (Right To Buy)
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.78 per share. 10 Jul 2024 1,270 1,072,076 - 15.8 20,041 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 23.10 per share. 24 Jun 2024 12,930 1,059,153 - 23.1 298,711 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.42 per share. 24 Jun 2024 12,930 1,072,083 - 14.4 186,451 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2024 12,930 577,070 - - Stock Option (Right To Buy)
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 27.13 per share. 08 Feb 2024 92,001 1,059,153 - 27.1 2,495,822 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.41 per share. 23 Jan 2024 5,696 1,151,154 - 18.4 104,851 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.31 per share. 15 Dec 2023 40,732 1,185,087 - 20.3 827,202 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 17.27 per share. 15 Dec 2023 28,632 1,230,521 - 17.3 494,432 Common Stock
4D Molecular Therapeutics Inc
Kirn David Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 19.56 per share. 15 Dec 2023 28,104 1,156,983 - 19.6 549,804 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.13 per share. 15 Dec 2023 4,702 1,225,819 - 18.1 85,243 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.11 per share. 15 Dec 2023 133 1,156,850 - 20.1 2,674 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2023 590,000 590,000 - - Stock Option (Right to Buy)
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 02 May 2023 600,000 1,259,153 - 0 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 02 May 2023 600,000 600,000 - 0 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.93 per share. 21 Feb 2023 17,090 1,876,509 - 20.9 357,718 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.22 per share. 21 Feb 2023 16,449 1,859,153 - 20.2 332,665 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 21.49 per share. 21 Feb 2023 907 1,875,602 - 21.5 19,491 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 222,000 222,000 - - Stock Option (Right to Buy)
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.03 per share. 19 Jan 2023 10,899 1,902,224 - 20.0 218,347 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.19 per share. 19 Jan 2023 8,625 1,893,599 - 20.2 174,127 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 23.56 per share. 15 Dec 2022 31,433 1,968,567 - 23.6 740,568 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 22.66 per share. 15 Dec 2022 27,595 1,939,472 - 22.7 625,372 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 23.39 per share. 15 Dec 2022 26,349 1,913,123 - 23.4 616,206 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 24.13 per share. 15 Dec 2022 1,500 1,967,067 - 24.1 36,199 Common Stock
4D Molecular Therapeutics Inc
David Kirn Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 150,000 150,000 - - Stock Option (Right to Buy)
4D Molecular Therapeutics Inc
David Kirn Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 150,000 150,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades